Detalles de la búsqueda
1.
Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer.
Int J Cancer
; 147(9): 2515-2525, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32488909
2.
Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers.
Int J Cancer
; 146(1): 223-235, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31444972
3.
Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma.
Ann Surg
; 271(3): 549-558, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30216219
4.
Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information.
BMC Cancer
; 20(1): 1107, 2020 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33198661
5.
Assessing Treatment Response and Prognosis by Serum and Tissue Metabolomics in Breast Cancer Patients.
J Proteome Res
; 18(10): 3649-3660, 2019 10 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31483662
6.
NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients.
Breast Cancer Res
; 20(1): 120, 2018 10 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30322396
7.
Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients.
Breast Cancer Res
; 19(1): 125, 2017 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29183390
8.
Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
Breast Cancer Res
; 19(1): 120, 2017 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29137653
9.
Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer.
Breast Cancer Res Treat
; 162(1): 127-137, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28058579
10.
Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases.
Ann Surg Oncol
; 24(8): 2113-2121, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28258416
11.
Circulating tumor cells in patients with colorectal liver metastasis predict impaired survival.
Ann Surg
; 261(1): 164-71, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24509211
12.
Detection of Circulating Tumor Cells at Surgery and at Follow-Up Assessment to Predict Survival After Two-Stage Liver Resection of Colorectal Liver Metastases.
Ann Surg Oncol
; 22(12): 4029-37, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25801354
13.
International study on inter-reader variability for circulating tumor cells in breast cancer.
Breast Cancer Res
; 16(2): R43, 2014 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-24758318
14.
Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients.
BMC Cancer
; 14: 514, 2014 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25023626
15.
Associations between tumor vascularization assessed by in vivo DCE-MRI and the presence of disseminated tumor cells in bone marrow in breast cancer patients at the time of diagnosis.
J Magn Reson Imaging
; 40(6): 1382-91, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24470360
16.
Combined analysis of vascular invasion, grade, HER2 and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy.
Acta Oncol
; 52(1): 91-101, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22934555
17.
Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival.
Breast Cancer Res
; 14(4): R117, 2012 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-22889108
18.
High-resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer.
Int J Cancer
; 131(4): E405-15, 2012 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21935921
19.
Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness.
Histopathology
; 61(3): 350-64, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22690749
20.
Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study.
BMC Cancer
; 12: 616, 2012 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-23259667